These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 8070016

  • 41. Multiple endonucleases function to repair covalent topoisomerase I complexes in Saccharomyces cerevisiae.
    Deng C, Brown JA, You D, Brown JM.
    Genetics; 2005 Jun; 170(2):591-600. PubMed ID: 15834151
    [Abstract] [Full Text] [Related]

  • 42. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
    Tanizawa A, Kohn KW, Kohlhagen G, Leteurtre F, Pommier Y.
    Biochemistry; 1995 May 30; 34(21):7200-6. PubMed ID: 7766631
    [Abstract] [Full Text] [Related]

  • 43. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen.
    Pommier Y, Kohlhagen G, Wu C, Simmons DT.
    Biochemistry; 1998 Mar 17; 37(11):3818-23. PubMed ID: 9521701
    [Abstract] [Full Text] [Related]

  • 44. Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons.
    van Waardenburg RC, de Jong LA, van Delft F, van Eijndhoven MA, Bohlander M, Bjornsti MA, Brouwer J, Schellens JH.
    Mol Cancer Ther; 2004 Apr 17; 3(4):393-402. PubMed ID: 15078982
    [Abstract] [Full Text] [Related]

  • 45. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
    Byl JA, Fortune JM, Burden DA, Nitiss JL, Utsugi T, Yamada Y, Osheroff N.
    Biochemistry; 1999 Nov 23; 38(47):15573-9. PubMed ID: 10569941
    [Abstract] [Full Text] [Related]

  • 46. Isolation of mutants of Saccharomyces cerevisiae requiring DNA topoisomerase I.
    Sadoff BU, Heath-Pagliuso S, Castaño IB, Zhu Y, Kieff FS, Christman MF.
    Genetics; 1995 Oct 23; 141(2):465-79. PubMed ID: 8647385
    [Abstract] [Full Text] [Related]

  • 47. Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance.
    Tanizawa A, Beitrand R, Kohlhagen G, Tabuchi A, Jenkins J, Pommier Y.
    J Biol Chem; 1993 Dec 05; 268(34):25463-8. PubMed ID: 8244980
    [Abstract] [Full Text] [Related]

  • 48. Two distinct mechanisms of Topoisomerase 1-dependent mutagenesis in yeast.
    Cho JE, Kim N, Li YC, Jinks-Robertson S.
    DNA Repair (Amst); 2013 Mar 01; 12(3):205-11. PubMed ID: 23305949
    [Abstract] [Full Text] [Related]

  • 49. Using yeast to understand drugs that target topoisomerases.
    Nitiss JL, Rose A, Sykes KC, Harris J, Zhou J.
    Ann N Y Acad Sci; 1996 Dec 13; 803():32-43. PubMed ID: 8993498
    [No Abstract] [Full Text] [Related]

  • 50. Identification of a small topoisomerase I-binding peptide that has synergistic antitumor activity with 9-aminocamptothecin.
    Pond CD, Marshall KM, Barrows LR.
    Mol Cancer Ther; 2006 Mar 13; 5(3):739-45. PubMed ID: 16546989
    [Abstract] [Full Text] [Related]

  • 51. Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutants.
    Brill SJ, Sternglanz R.
    Cell; 1988 Jul 29; 54(3):403-11. PubMed ID: 2840207
    [Abstract] [Full Text] [Related]

  • 52. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
    Nitiss JL, Nitiss KC.
    Methods Mol Biol; 2001 Jul 29; 95():315-27. PubMed ID: 11089243
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage.
    Reid RJ, Fiorani P, Sugawara M, Bjornsti MA.
    Proc Natl Acad Sci U S A; 1999 Sep 28; 96(20):11440-5. PubMed ID: 10500195
    [Abstract] [Full Text] [Related]

  • 55. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.
    Wasserman RA, Wang JC.
    Cancer Res; 1994 Apr 01; 54(7):1795-800. PubMed ID: 8137294
    [Abstract] [Full Text] [Related]

  • 56. Structural insight of DNA topoisomerases I from camptothecin-producing plants revealed by molecular dynamics simulations.
    Sirikantaramas S, Meeprasert A, Rungrotmongkol T, Fuji H, Hoshino T, Sudo H, Yamazaki M, Saito K.
    Phytochemistry; 2015 May 01; 113():50-6. PubMed ID: 25733498
    [Abstract] [Full Text] [Related]

  • 57. Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle arrest and cell death.
    Megonigal MD, Fertala J, Bjornsti MA.
    J Biol Chem; 1997 May 09; 272(19):12801-8. PubMed ID: 9139740
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I.
    Colley WC, van der Merwe M, Vance JR, Burgin AB, Bjornsti MA.
    J Biol Chem; 2004 Dec 24; 279(52):54069-78. PubMed ID: 15489506
    [Abstract] [Full Text] [Related]

  • 60. A Yeast-Based Screening System for Differential Identification of Poisons and Suppressors of Human Topoisomerase I.
    Seddek A, Madeira C, Annamalai T, Mederos C, Tiwari PB, Welch AZ, Tse-Dinh YC.
    Front Biosci (Landmark Ed); 2022 Mar 09; 27(3):93. PubMed ID: 35345325
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.